FilingPulse

ELTX insider transaction filings

Elicio Therapeutics, Inc. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-17. Screen ELTX transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-174DeMuth Peter — Chief Scientific OfficerGrant/award (A): 52,832 (derivative) @ $0EDGAR
2026-07-174Connelly Robert — CEO, President and Director, DirectorGrant/award (A): 186,944 (derivative) @ $0EDGAR
2026-07-174Shah Preetam — See RemarksGrant/award (A): 60,833 (derivative) @ $0EDGAR
2026-07-174Haqq Christopher — See RemarksGrant/award (A): 64,643 (derivative) @ $0EDGAR
2026-02-034Connelly Robert — CEO, President and Director, DirectorGrant/award (A): 73,600 @ $0 · Grant/award (A): 147,200 (derivative) @ $0EDGAR
2026-02-034Shah Preetam — See RemarksGrant/award (A): 24,000 @ $0 · Grant/award (A): 47,900 (derivative) @ $0EDGAR
2026-02-034DeMuth Peter — Chief Scientific OfficerGrant/award (A): 20,800 @ $0 · Grant/award (A): 41,600 (derivative) @ $0EDGAR
2026-02-034Haqq Christopher — See RemarksGrant/award (A): 25,400 @ $0 · Grant/award (A): 50,900 (derivative) @ $0EDGAR
2025-12-104DeMuth Peter — Chief Scientific OfficerOption exercise (M): 362 @ $4.41 · Option exercise (M): 362 (derivative) @ $0EDGAR
2025-06-044Chudnovsky Yekaterina — Director, 10% owner
GKCC, LLC — 10% owner		Grant/award (A): 103,225 (derivative) @ $0EDGAR
2025-05-204Ashe Carol Gail — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204Chudnovsky Yekaterina — Director, 10% ownerGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204Nissenson Allen — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204Venkatesan Jay — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204WILSON KAREN J — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204ADAMS JULIAN — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-05-204RUFFOLO ROBERT R — DirectorGrant/award (A): 7,900 (derivative) @ $0EDGAR
2025-04-164Shah Preetam — See RemarksGrant/award (A): 191,624 (derivative) @ $0EDGAR
2025-03-074Chudnovsky Yekaterina — Director, 10% owner
GKCC, LLC — 10% owner		Conversion (C): 3,500,573 @ $5.81 · Conversion (C): 3,442,341 (derivative) @ $5.81EDGAR
2025-02-044DeMuth Peter — Chief Scientific OfficerGrant/award (A): 44,400 (derivative) @ $0EDGAR
2025-02-044Haqq Christopher — See RemarksGrant/award (A): 44,000 (derivative) @ $0EDGAR
2025-02-044Connelly Robert — CEO, President and Director, DirectorGrant/award (A): 121,600 (derivative) @ $0EDGAR

Recent 8-K events — Elicio Therapeutics, Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-07-028-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
2026-06-248-K7.01 — Regulation FD DisclosureEDGAR
2026-06-178-K8.01 — Other EventsEDGAR
2026-06-158-K8.01 — Other EventsEDGAR
2026-05-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits		EDGAR
2026-03-168-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement		EDGAR
2026-03-128-K2.02 — Results of Operations and Financial ConditionEDGAR
2025-11-138-K2.02 — Results of Operations and Financial ConditionEDGAR
2025-09-178-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits		EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ELTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →